Standard BioTools Inc.LABNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P38
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -4.73% |
| Q3 2025 | -5.37% |
| Q2 2025 | -27.39% |
| Q1 2025 | 2.98% |
| Q4 2024 | 9.26% |
| Q3 2024 | 38.39% |
| Q2 2024 | -47.04% |
| Q1 2024 | 119.83% |
| Q4 2023 | -4.21% |
| Q3 2023 | -1.36% |
| Q2 2023 | 6.13% |
| Q1 2023 | -10.91% |
| Q4 2022 | -9.26% |
| Q3 2022 | -12.45% |
| Q2 2022 | -2.56% |
| Q1 2022 | 34.47% |
| Q4 2021 | -4.62% |
| Q3 2021 | -0.73% |
| Q2 2021 | -12.17% |
| Q1 2021 | -13.55% |
| Q4 2020 | 40.96% |
| Q3 2020 | 9.89% |
| Q2 2020 | -9.16% |
| Q1 2020 | 20.78% |
| Q4 2019 | -9.35% |
| Q3 2019 | -6.35% |
| Q2 2019 | -3.02% |
| Q1 2019 | 3.88% |
| Q4 2018 | 9.75% |
| Q3 2018 | 5.44% |
| Q2 2018 | 0.97% |
| Q1 2018 | 18.55% |
| Q4 2017 | -21.09% |
| Q3 2017 | -4.16% |
| Q2 2017 | -7.09% |
| Q1 2017 | -0.85% |
| Q4 2016 | 7.79% |
| Q3 2016 | -11.42% |
| Q2 2016 | -6.40% |
| Q1 2016 | 15.35% |